Skip to main content
Experience with Axicabtagene Ciloleucel (Axi-cel) in Patients with Secondary CNS Involvement: Results from the US Lymphoma CAR T Consortium Bennani, N., Maurer, M. J., Nastoupil, L. J., Jain, M. D., Chavez, J. C., Cashen, A. F., Dahiya, S., Lekakis, L. J., Reagan, P. M., Oluwole, O. O., McGuirk, J. P., Deol, A., Sehgal, A. R., Goy, A., Hill, B. T., Vu, K., Andreadis, C., Munoz, J., Rapoport, A. P., Vose, J. M., Miklos, D. B., Locke, F. L., Neelapu, S. S., Lin, Y. AMER SOC HEMATOLOGY. 2019

View details for DOI 10.1182/blood-2019-129097

View details for Web of Science ID 000518218500614